The Scientific Frontier

Drug Discovery

6 articles

Futuristic laboratory scene with AI generating molecules, symbolizing the dual-use potential of AI in biotechnology and its ethical challenges.
Biotechnology & Genetics

AI in biotech poses ethical dilemmas

In a chilling demonstration, researchers weaponized AI-driven drug discovery systems, generating 40,000 toxic molecules and a nerve agent within several hours.

Maria Flores·September 2, 2026
A quantum computer in a futuristic lab setting, visualizing AI-driven drug discovery with glowing molecular structures and data streams.
Computational Science & Software

Danish team uses quantum computer to boost AI drug discovery

A team at the Technical University of Denmark, leveraging an Orca Computing quantum computer, has dramatically improved the accuracy and reach of generative AI models for drug discovery.

Yasmin Haddad·August 1, 2026
Scientists using AI in a lab to design new medicines for endangered species, with holographic displays of animals in the background.
Cosmos & Physics

Nature drug designers will create new medicines for endangered species

At a laboratory in Michigan, chemist Tim Cernak is developing a precision insecticide to protect hemlock trees from invasive species.

Dr. Evelyn Reed·June 11, 2026
AI interface displaying molecular data for whole-body rejuvenation drug discovery in a high-tech laboratory setting.
Health & Medicine

AI Accelerates Whole-Body Rejuvenation Drug Discoveries

Biotech startup NewLimit recently secured $435 million from investors, including Founders Fund, for its age reprogramming efforts.

Dr. Chloe O'Connell·June 10, 2026
Advanced artificial intelligence interface designing custom miniproteins to precisely control G protein-coupled receptor signaling in a cellular environment.
Cosmos & Physics

AI designs miniproteins to precisely control GPCR signaling

For the first time, artificial intelligence has designed custom miniproteins that precisely modulate G protein-coupled receptor (GPCR) signaling in cells.

Dr. Evelyn Reed·May 21, 2026
A glowing, complex quintuple agonist molecule in a futuristic lab, representing a breakthrough in obesity and diabetes treatment.
Cosmos & Physics

New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice

In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP

Dr. Evelyn Reed·May 18, 2026